Page last updated: 2024-09-03

2-(2,3-dicarboxycyclopropyl)glycine and 3,4-dicarboxyphenylglycine

2-(2,3-dicarboxycyclopropyl)glycine has been researched along with 3,4-dicarboxyphenylglycine in 1 studies

Compound Research Comparison

Studies
(2-(2,3-dicarboxycyclopropyl)glycine)
Trials
(2-(2,3-dicarboxycyclopropyl)glycine)
Recent Studies (post-2010)
(2-(2,3-dicarboxycyclopropyl)glycine)
Studies
(3,4-dicarboxyphenylglycine)
Trials
(3,4-dicarboxyphenylglycine)
Recent Studies (post-2010) (3,4-dicarboxyphenylglycine)
1401502

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanco-Urgoiti, J; Bueno, AB; Collado, I; González, R; Griffey, KI; Hoard, DW; Johnson, BG; Kingston, AE; Marcos, A; Moher, ED; Pedregal, C; Pérez-Castells, J; Schoepp, DD; Tizzano, JP; Wright, RA1

Other Studies

1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and 3,4-dicarboxyphenylglycine

ArticleYear
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
    Journal of medicinal chemistry, 2004, Jan-15, Volume: 47, Issue:2

    Topics: Administration, Oral; Animals; Cerebral Cortex; Cyclic AMP; Fear; Glycine; In Vitro Techniques; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reflex, Startle; Stereoisomerism; Structure-Activity Relationship

2004